BALCHEM CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.0B | $953.7M | $922.4M | $942.4M | $799.0M |
| Gross profit | $370.6M | $336.2M | $302.1M | $280.5M | $243.2M |
| Operating income | $209.3M | $182.9M | $159.2M | $145.2M | $127.5M |
| Operating expenses | $161.3M | $153.3M | $142.9M | $135.3M | $115.7M |
| Cost of revenue | $666.5M | $617.5M | $620.4M | $661.9M | $555.8M |
| Cash from operations | $216.6M | $182.0M | $183.8M | $138.5M | $160.5M |
| Capital expenditure | — | — | — | $49.1M | $36.1M |
| Free cash flow | — | — | — | $89.5M | $124.4M |
| Share repurchases | $107.6M | $5.7M | $4.5M | $35.4M | $35.2M |
| Impairments | $0 | $521,000 | $7.8M | $23,000 | $1.7M |
| Total assets | $1.7B | $1.6B | $1.6B | $1.6B | $1.2B |
| Total liabilities | $428.8M | $425.5M | $543.2M | $686.2M | $322.3M |
Shares outstanding 32.1M · Free float 98.4%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.